Synthetic Substances for Diversion and Control Purposes

The Drug Enforcement Administration is soliciting bids for 34 line items of synthetic substances required for pharmacological testing and diversion control purposes. This procurement, issued under solicitation number D-26-DO-0004, is open to all qualified vendors with no set-aside restrictions and is classified under NAICS code 325199 (All Other Basic Organic Chemical Manufacturing). Prospective contractors must demonstrate capability to handle controlled substances and comply with all applicable regulatory requirements for the materials being procured. The DEA will evaluate submissions using a lowest price technically acceptable (LPTA) source selection methodology, considering technical acceptability, past performance, and pricing, with potential for award without discussions. Questions regarding the solicitation must be submitted by January 15, 2026 at 11:00 AM EST, with the proposal due date of January 20, 2026 at 2:00 PM EST, which represents an expedited procurement timeline.

This is a full and open procurement with no set-aside designation, applicable to businesses meeting the 1,250-employee size standard threshold. The synthetic substances being procured range in quantities from 1 gram to 100 milligrams, including compounds such as N-isobutyl Pentylone, Cloniprazpam, and MDMB-PINACA, with the contract also requiring provision of Disposable Grinding Chambers. The place of performance is Dulles, Virginia 20166, with a required delivery date of August 31, 2026. While specific award values are not disclosed in the solicitation documents, the procurement encompasses 34 distinct line items with varying quantities and specifications. Interested vendors should note that some substances included in this procurement are classified as controlled substances, necessitating appropriate regulatory compliance capabilities and handling procedures.